HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Otto Appenzeller Selected Research

Otto Appenzeller Research Topics

Disease

6Hypoxia (Hypoxemia)
01/2018 - 03/2003
1Tuberculosis (Tuberculoses)
09/2018
1Pulmonary Tuberculosis
05/2018
1Cystic Fibrosis (Mucoviscidosis)
05/2018
1Necrosis
04/2018
1Soft Tissue Infections
04/2018
1Disease Susceptibility (Diathesis)
10/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2007
1Ataxia Telangiectasia (Louis Bar Syndrome)
08/2006

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006 - 03/2003
2human VEGFA proteinIBA
06/2006 - 03/2003
1Streptomycin (Streptomycin Sulfate)FDA Link
09/2018
1TrypsinIBA
05/2018
1Anti-Bacterial Agents (Antibiotics)IBA
04/2018
1Local Anti-Infective Agents (Antiseptics)IBA
04/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1PlasticsIBA
01/2012
1NitrogenIBA
01/2012
1GasesIBA
01/2012
1Biomarkers (Surrogate Marker)IBA
10/2008
1Tricarboxylic AcidsIBA
10/2008
1IsotopesIBA
07/2007
1Neuroprotective AgentsIBA
07/2007
1Nicotinamide MononucleotideIBA
08/2006
1EnzymesIBA
08/2006
1glutamine-synthetase adenylyltransferaseIBA
08/2006
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
06/2006
1CatecholsIBA
02/2006
1CatecholaminesIBA
02/2006
1Proteins (Proteins, Gene)FDA Link
03/2003
1Oxygen (Dioxygen)IBA
03/2003

Therapy/Procedure

1Cautery
04/2018